Skip to main content

Advertisement

SpringerLink
Log in

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective

To assess postmenopausal breast cancer risk in relation to particular patterns of oral contraceptive (OC) use according to hormone replacement therapy (HRT) exposure.

Methods

Time-dependent Cox regression models were used to analyse information on postmenopausal women from a large-scale French cohort. Among a total of 68,670 women born between 1925 and 1950, 1405 primary invasive postmenopausal breast cancer cases were identified from 1992 to 2000.

Results

A non-significant decrease in risk of around 10% was associated with ever OC use as compared to never OC use in postmenopausal women. No significant interaction was found between OC and HRT use on postmenopausal breast cancer risk. Breast cancer risk decreased significantly with increasing time since first OC use (test for trend: p=0.01); this was consistent after adjustment for duration of use or for time since last use.

Conclusion

No increase in breast cancer risk was associated with previous OC exposure among postmenopausal women, probably because the induction window had closed. Some women may develop breast cancer soon after exposure to OCs, leading to a deficit of cases of older women. Further investigation is therefore required to identify young women at high risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. InstitutionalAuthorNameCollaborative Group on Hormonal Factors in Breast Cancer (1996) ArticleTitleBreast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies Lancet 347 1713–1727

    Google Scholar 

  2. MD Althuis DR Brogan RJ Coates et al. (2003) ArticleTitleHormonal content and potency of oral contraceptives and breast cancer risk among young women Br J Cancer 88 50–57 Occurrence Handle10.1038/sj.bjc.6600691 Occurrence Handle1:CAS:528:DC%2BD3sXntFSguw%3D%3D Occurrence Handle12556959

    Article  CAS  PubMed  Google Scholar 

  3. M Kumle E Weiderpass T Braaten I Persson HO Adami E Lund (2002) ArticleTitleUse of oral contraceptives and breast cancer risk: the Norwegian-Swedish Women’s Lifestyle and Health Cohort Study Cancer Epidemiol Biomarkers Prev 11 1375–1381 Occurrence Handle1:CAS:528:DC%2BD38XpsVyksrY%3D Occurrence Handle12433714

    CAS  PubMed  Google Scholar 

  4. G Ursin RK Ross J Sullivan-Halley R Hanish B Henderson L Bernstein (1998) ArticleTitleUse of oral contraceptives and risk of breast cancer in young women Breast Cancer Res Treat 50 175–184 Occurrence Handle10.1023/A:1006037823178 Occurrence Handle1:CAS:528:DyaK1cXntlCrtbc%3D Occurrence Handle9822222

    Article  CAS  PubMed  Google Scholar 

  5. WC Chie CY Li CS Huang KJ Chang ML Yen RS Lin (1998) ArticleTitleOral contraceptives and breast cancer in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives Int J Cancer 77 219–223 Occurrence Handle10.1002/(SICI)1097-0215(19980717)77:2<219::AID-IJC9>3.0.CO;2-T Occurrence Handle1:STN:280:DyaK1czht1GktA%3D%3D Occurrence Handle9650556

    Article  CAS  PubMed  Google Scholar 

  6. PA Marchbanks JA Mc Donald HG Wilson et al. (2002) ArticleTitleOral contraceptives and risk of breast cancer N Engl J Med 346 2025–2032 Occurrence Handle10.1056/NEJMoa013202 Occurrence Handle1:CAS:528:DC%2BD38XkvFartLc%3D Occurrence Handle12087137

    Article  CAS  PubMed  Google Scholar 

  7. C Van Hoften H Burger PHM Peeters DE Grobbe PAH Van Noord HGM Leufkens (2000) ArticleTitleLong term oral contraceptive use increases breast cancer risk in women over 55 years of age: the DOM cohort Int J Cancer 87 591–594 Occurrence Handle10.1002/1097-0215(20000815)87:4<591::AID-IJC20>3.0.CO;2-C Occurrence Handle1:CAS:528:DC%2BD3cXlvVyms70%3D Occurrence Handle10918202

    Article  CAS  PubMed  Google Scholar 

  8. InstitutionalAuthorNameMillion Women Study Collaborators (2003) ArticleTitleBreast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419–427

    Google Scholar 

  9. InstitutionalAuthorNameWriting Group for the Women’s Health Initiative Investigators (2002) ArticleTitleRisk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial JAMA 288 321–333

    Google Scholar 

  10. InstitutionalAuthorNameCollaborative Group on Hormonal Factors in Breast Cancer (1997) ArticleTitleBreast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 1047–1059

    Google Scholar 

  11. K Bakken E Alsaker AE Eggen E Lund (2004) ArticleTitleHormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study Int J Cancer 112 130–134 Occurrence Handle10.1002/ijc.20389 Occurrence Handle1:CAS:528:DC%2BD2cXnvVWltrg%3D Occurrence Handle15305384

    Article  CAS  PubMed  Google Scholar 

  12. Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F (2004) Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer (in press).

  13. SA Norman JA Berlin AL Weber et al. (2003) ArticleTitleCombined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women Cancer Causes Control 14 933–943 Occurrence Handle10.1023/B:CACO.0000007967.25865.29 Occurrence Handle14750532

    Article  PubMed  Google Scholar 

  14. G Ursin CC Tseng A Paganini-Hill et al. (2002) ArticleTitleDoes menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol 20 699–706 Occurrence Handle10.1200/JCO.20.3.699 Occurrence Handle1:CAS:528:DC%2BD38XhsVGmt7w%3D Occurrence Handle11821451

    Article  CAS  PubMed  Google Scholar 

  15. LA Brinton DR Brogan RJ Coates CA Swanson N Potischman JL Stanford (1998) ArticleTitleBreast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy Menopause 5 145–151 Occurrence Handle1:STN:280:DyaK1cvkslyrtw%3D%3D Occurrence Handle9774759

    CAS  PubMed  Google Scholar 

  16. InstitutionalAuthorNameCollaborative Group on Hormonal Factors in Breast Cancer (1996) ArticleTitleBreast cancer and hormonal contraceptives: Further results Contraception 54 IssueIDSuppl.3 1S–106S

    Google Scholar 

  17. AG Schuurman A Brandt Particlevan den RA Goldbohm (1995) ArticleTitleExogenous hormone use and the risk of postmenopausal breast cancer: results from the Netherlands Cohort Study Cancer Causes Control 6 416–424 Occurrence Handle10.1007/BF00052181 Occurrence Handle1:STN:280:BymD2MfltVE%3D Occurrence Handle8547539

    Article  CAS  PubMed  Google Scholar 

  18. JL Stanford NS Weiss LF Voigt JR Daling LA Hable MA Rossing (1995) ArticleTitleCombined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women JAMA 274 137–142 Occurrence Handle10.1001/jama.274.2.137 Occurrence Handle1:STN:280:ByqA3Mbgt1E%3D Occurrence Handle7596001

    Article  CAS  PubMed  Google Scholar 

  19. M Clemons P Goss (2001) ArticleTitleEstrogen and the risk of breast cancer N Engl J Med 344 276–285 Occurrence Handle1:CAS:528:DC%2BD3MXht1Sruro%3D Occurrence Handle11172156

    CAS  PubMed  Google Scholar 

  20. F Clavel-Chapelon MJ Liere Particlevan C Guibout et al. (1997) ArticleTitleE3N, a French cohort study on cancer risk factors Eur J Cancer Prev 6 473–478 Occurrence Handle1:STN:280:DyaK1c7islaltA%3D%3D Occurrence Handle9466118

    CAS  PubMed  Google Scholar 

  21. E Riboli (1992) ArticleTitleNutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC) Ann Oncol 3 783–791 Occurrence Handle1:STN:280:ByyC28%2Fgs1I%3D Occurrence Handle1286041

    CAS  PubMed  Google Scholar 

  22. DG Altman BL De Stavola (1994) ArticleTitlePractical problems in fitting a proportional hazards model to data with updated measurements of the covariates Stat Med 13 301–341 Occurrence Handle1:STN:280:ByuB3szitVY%3D Occurrence Handle8177984

    CAS  PubMed  Google Scholar 

  23. CMA Thiébaut J Bénichou (2004) ArticleTitleChoice of time-scale in Cox’s model analysis of epidemiologic cohort data: a simulation study Stat Med 23 3803–3820 Occurrence Handle15580597

    PubMed  Google Scholar 

  24. C Schairer J Lubin R Troisi S Sturgeon L Brinton R Hoover (2000) ArticleTitleMenopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk JAMA 283 485–491 Occurrence Handle1:CAS:528:DC%2BD3cXns1GltA%3D%3D Occurrence Handle10659874

    CAS  PubMed  Google Scholar 

  25. S Greenland (1998) Applications of stratified analysis methods KJ Rothman S Greenland (Eds) Modern Epidemiology EditionNumber2 Lippincott-Raven Philadelphia 297–300

    Google Scholar 

  26. PA Wingo NC Lee HW Ory V Beral HB Peterson P Rhodes (1993) ArticleTitleAge-specific differences in the relationship between oral contraceptive use and breast cancer Cancer 71 IssueIDsuppl 1506–1517 Occurrence Handle1:STN:280:ByyC287ivVc%3D Occurrence Handle8431887

    CAS  PubMed  Google Scholar 

  27. MD Althuis DD Brogan RJ Coates et al. (2003) ArticleTitleBreast cancers among very young premenopausal women (United States) Cancer Causes Control 14 151–160 Occurrence Handle12749720

    PubMed  Google Scholar 

  28. V Dumeaux E Alsaker E Lund (2003) ArticleTitleBreast cancer and specific types of oral contraceptives: a large Norwegian cohort study Int J cancer 105 844–850 Occurrence Handle1:CAS:528:DC%2BD3sXltVSisbw%3D Occurrence Handle12767072

    CAS  PubMed  Google Scholar 

  29. E White KE Malone NS Weiss JR Daling (1994) ArticleTitleBreast cancer among young US women in relation to oral contraceptive use J Natl Cancer Inst 86 505–514 Occurrence Handle1:STN:280:ByuC1c%2FktVI%3D Occurrence Handle8133534

    CAS  PubMed  Google Scholar 

  30. K McPherson MP Vessey A Neil R Doll L Jones M Roberts (1987) ArticleTitleEarly oral contraceptive use and breast cancer: results of another case–control study Br J Cancer 56 653–660 Occurrence Handle1:STN:280:BieC3cjjvFI%3D Occurrence Handle3426932

    CAS  PubMed  Google Scholar 

  31. MA Rookus FE Van Leeuwen (1994) ArticleTitleOral contraceptives and risk of breast cancer in women aged 20–54 years Lancet 344 844–851 Occurrence Handle1:STN:280:ByuA2snltl0%3D Occurrence Handle7916400

    CAS  PubMed  Google Scholar 

  32. LA Brinton JR Daling JM Liff JB Schoenberg (1995) ArticleTitleOral contraceptives and breast cancer risk among younger women J Natl Cancer Inst 87 827–835 Occurrence Handle1:STN:280:ByqA3M7jtlY%3D Occurrence Handle7791232

    CAS  PubMed  Google Scholar 

  33. AS Whittemore (1977) ArticleTitleThe age distribution of human cancer for carcinogenic exposures of varying intensity Am J Epidemiol 106 418–432 Occurrence Handle1:STN:280:CSeD3sjpt1A%3D Occurrence Handle920729

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Community Medicine, University of Tromsø, France

    Vanessa Dumeaux & Eiliv Lund

  2. Institut Gustave-Roussy, INSERM “Nutrition, Hormones, Cancer”, Equipe E3N-EPIC, Villejuif, France

    Vanessa Dumeaux, Agnès Fournier & Françoise Clavel-Chapelon

Authors
  1. Vanessa Dumeaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Agnès Fournier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eiliv Lund
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Françoise Clavel-Chapelon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Françoise Clavel-Chapelon.

Additional information

* Address correspondence to: F. Clavel-Chapelon, Equipe E3N-EPIC, INSERM “Nutrition, Hormones, Cancer”, Institut Gustave-Roussy, 94805 – Villejuif, France.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dumeaux, V., Fournier, A., Lund, E. et al. Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. Cancer Causes Control 16, 537–544 (2005). https://doi.org/10.1007/s10552-004-8024-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-004-8024-z

Keywords

Search

Navigation